New frontiers for anti-biofilm drug development

Pharmacology & Therapeutics
Suzana M RibeiroOctávio L Franco

Abstract

Pathogenic microbial biofilm, a consortium of microbial cells protected by a self-produced polymer matrix, is considered a worldwide challenge due to the inherent antibiotic resistance conferred by its lifestyle. Living, as it does, in a community of microbial organisms in a clinical situation, makes it responsible for severe and dangerous cases of infection. Combating this organisation of cells usually requires high antibiotic doses for a prolonged time, and these approaches often fail, contributing to infection persistence. In addition to therapeutic limitations, biofilms can be a source of infections when they grow in medical devices. The challenge imposed by biofilms has mobilised researchers in the entire world to prospect or develop alternatives to control biofilms. In this context, this review summarises the new frontiers that could be used in clinical circumstances in order to prevent or eliminate pathogenic biofilms.

References

Jun 7, 2000·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·R H MüllerS Gohla
Jun 16, 2000·Applied Microbiology and Biotechnology·I M BanatS S Cameotra
Jul 27, 2002·Annual Review of Microbiology·John S Mattick
Dec 25, 2003·Antimicrobial Agents and Chemotherapy·Mohammed A S Alem, L Julia Douglas
Oct 13, 2004·Proceedings of the National Academy of Sciences of the United States of America·Xiaojun ZhaoWeihong Tan
Feb 3, 2005·Nature Reviews. Drug Discovery·Vladimir P Torchilin
Jun 28, 2005·Biomaterials·Brian J NabloMark H Schoenfisch
Sep 30, 2005·Journal of Medical Microbiology·Mohammed A S Alem, L Julia Douglas
Mar 16, 2006·Bioconjugate Chemistry·Matthias GabrielAndrej Zentner
Oct 20, 2006·Bioorganic & Medicinal Chemistry Letters·Edward TurosDaniel V Lim
Mar 8, 2007·Bioconjugate Chemistry·Lin WangWeihong Tan
Jun 6, 2007·Water Science and Technology : a Journal of the International Association on Water Pollution Research·C PicioreanuS Molin
Jul 25, 2007·Antimicrobial Agents and Chemotherapy·Akira ShimotoyodomeYoshinori Takaesu
Oct 24, 2007·The Veterinary Clinics of North America. Small Animal Practice·Anthony J Mutsaers
Feb 6, 2008·Acta Biomaterialia·Jayesh P RupareliaSuparna Mukherji
Feb 29, 2008·The Journal of Antimicrobial Chemotherapy·David RoeJean-Baptiste Roullet
Jul 2, 2008·Infection and Immunity·Joerg OverhageRobert E W Hancock
Oct 30, 2008·Nucleic Acids Research·Guangshun WangZhe Wang
Nov 20, 2008·Journal of Applied Microbiology·M D P WillcoxN Cole
Jan 27, 2009·American Journal of Respiratory Cell and Molecular Biology·Sophie Moreau-MarquisBruce A Stanton
Jan 28, 2009·Chemistry & Biology·Kai HilpertRobert E W Hancock
Feb 24, 2009·Biomaterials·Evan M HetrickMark H Schoenfisch
May 19, 2009·The Journal of Antimicrobial Chemotherapy·Rabih O DarouicheSrinivasa Madhyastha
Jul 17, 2009·PloS One·Tim C R ConibearJeremy S Webb
Jul 29, 2009·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Lingzhou ZhaoZhifen Wu
Aug 8, 2009·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Clark F SchierleRobert D Galiano
Aug 12, 2009·Biomaterials·Jonathan LelloucheEhud Banin
Feb 13, 2010·International Journal of Antimicrobial Agents·Niels HøibyOana Ciofu
Mar 30, 2010·Burns : Journal of the International Society for Burn Injuries·Roba KhundkarTim Burge
Jun 10, 2010·FEMS Immunology and Medical Microbiology·Louise CarsonBrendan F Gilmore
Jun 23, 2010·The Journal of Biological Chemistry·Carla S AlvesMiguel A R B Castanho
Jul 16, 2010·Dental Clinics of North America·Philip D Marsh

❮ Previous
Next ❯

Citations

Mar 31, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alan R HauserDonald T Moir
Oct 22, 2016·Trends in Microbiology·Gerard D Wright
Sep 15, 2016·Expert Review of Anti-infective Therapy·Jeffrey A MelvinJennifer M Bomberger
Sep 13, 2016·Journal of Infection and Public Health·Marianne FrieriAnthony Boutin
Dec 9, 2016·Journal of Applied Microbiology·M D FerrerA Mira
Jun 20, 2017·Natural Product Reports·Francesc Rabanal, Yolanda Cajal
Mar 8, 2018·Current Infectious Disease Reports·Nathaniel J RhodesAlan R Hauser
Dec 16, 2017·Clinical Oral Investigations·Luca PirracchioSigrun Eick
Sep 12, 2018·Nanomaterials·Alexandra-Cristina BurdușelEcaterina Andronescu
Sep 12, 2019·International Journal of Environmental Health Research·Katarzyna ParaszkiewiczPrzemysław Bernat
Dec 1, 2019·Current Microbiology·Antônio Wilton Cavalcante FernandesMateus Matiuzzi da Costa
Nov 2, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ariadna Thalia Bernal-MercadoJesus Fernando Ayala-Zavala
Jul 13, 2019·Pharmaceutics·Emilia GaldieroRosa Carotenuto
Jul 11, 2018·Frontiers in Chemistry·Patrícia M CarvalhoMarco M Domingues
Nov 5, 2019·Frontiers in Microbiology·Karen G N OshiroOctávio Luiz Franco
Sep 22, 2019·International Journal of Molecular Sciences·Vivian A SalazarEster Boix
May 21, 2018·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Zahra SadrearhamiCyrille Boyer
Dec 22, 2019·Journal of Fungi·Maria Elisa RodriguesCélia F Rodrigues
Feb 4, 2021·Critical Reviews in Biotechnology·Mairim Russo SerafiniIzabel Almeida Alves
Mar 31, 2019·Biochimica Et Biophysica Acta. Biomembranes·Isabel C M FensterseiferOctavio L Franco
Jul 11, 2020·Current Topics in Medicinal Chemistry·Lialyz Soares Pereira AndréFábio Aguiar-Alves
Nov 14, 2020·Carbohydrate Polymers·Durairajan RubiniParamasivam Nithyanand
Jan 14, 2020·ACS Applied Materials & Interfaces·Crisiane A MarangonMarcia Nitschke

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Future Medicinal Chemistry
Andreas S Jacobsen, Håvard Jenssen
Clinical Otolaryngology and Allied Sciences
Francis J Lannigan
FEMS Immunology and Medical Microbiology
Liang YangMichael Givskov
© 2022 Meta ULC. All rights reserved